The global prenatal testing and newborn screening market is projected to be worth USD 10.85 Billion by 2027, according to a current analysis by Emergen Research. The prenatal testing and newborn screening market is observing high demand attributed to its increasing application in detecting fetal chromosome defects. Prenatal testing is considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.
The latest market intelligence study on the Prenatal Testing and Newborn Screening market performs an extensive analysis of the competitive landscape and growing investment pocket of the Prenatal Testing and Newborn Screening market for the forecast period, 2020 – 2027. The tailor-made study probes into the current and future trends of that are likely to shape the development of the Prenatal Testing and Newborn Screening industry to give the business owners a competitive edge and help them stay ahead of their rivals. The best of both research techniques including qualitative and quantitative are applied to gauge the market size, share, and growth rate.
You Can Download Free Sample PDF Copy of Prenatal Testing and Newborn Screening Market at https://www.emergenresearch.com/request-sample/346
Here are the questions we answer…
What are the future opportunities in store for the vendors operating in the Prenatal Testing and Newborn Screening market?
What does the competitive landscape look like?
Which emerging technologies are believed to impact the Prenatal Testing and Newborn Screening market performance?
What are the key trends and dynamics?
Which regulations that will impact the industry?
Which segment will offer the most opportunity for growth between 2020 and 2027?
Where will most developments take place in the long term?
Who are the most prominent vendors and how much market share do they occupy?
What are the latest technologies or discoveries influencing the Prenatal Testing and Newborn Screening market growth worldwide?
Market Segments
The global Prenatal Testing and Newborn Screening market has been categorized based on the product type, application, and region. Our expert analysts undertake a thorough assessment of all of the segments included in the report and analyze them based on their market share, revenue, market growth rate, and other vital factors. The segmentation allows the interested parties to determine sectors in the global Prenatal Testing and Newborn Screening market with high growth prospects and understand the growth strategies adopted by leading segments during the forecast period.
You Can Download Free Sample PDF Copy of Prenatal Testing and Newborn Screening Market at https://www.emergenresearch.com/request-sample/346
Key Highlights From The Report
In April 2019, Progenity Inc. made an announcement about the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.
Ultrasonography is projected to observe a significant growth rate in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.
The hospital held a substantial market share in 2019 due to the growing introduction of non-invasive prenatal testing, coupled with rapid technological developments in newborn screening, the presence of skilled professionals, and better reimbursement scenario.
North America dominated the market for Prenatal Testing and Newborn Screening in 2019 due to the availability of technologically advanced healthcare research system and developments in whole-genome sequencing.
Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.
Type Outlook (Revenue, USD Billion; 2017-2027)
Prenatal Testing
Newborn Screening
Test Type Outlook (Revenue, USD Billion; 2017-2027)
Non-Invasive
Invasive
Technology Outlook (Revenue, USD Billion; 2017-2027)
Mass Spectrometry
Electrophoresis
Enzyme Immunoassays
DNA Assays
Instrument Outlook (Revenue, USD Billion; 2017-2027)
Ultrasonography
Reagent and Assay Kits
Tandem Quadrupole Detector
Incubator Shaker
Hearing Screen Instruments
End Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Regional Outlook (Revenue: USD Billion; Volume: Million MT; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Read more@ https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Prenatal Testing and Newborn Screening Market Segmentation & Impact Analysis
Chapter 5. Prenatal Testing and Newborn Screening Market By Technology Insights & Trends, Revenue (USD Billion) (Million MT)
Chapter 6. Prenatal Testing and Newborn Screening Market By End-Use Verticals Insights & Trends Revenue (USD Billion) (Million MT)
Chapter 7. Prenatal Testing and Newborn Screening Market Regional Outlook
Continued…
Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market